As medical professionals, we continually strive to understand the intricacies of diseases that affect the human body. One such condition is Parkinson's disease (PD), a neurodegenerative disorder with a multifaceted etiology and presentation.
PD is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta. This loss leads to decreased striatal dopamine levels, disrupting the balance between the direct and indirect pathways of the basal ganglia, resulting in motor symptoms.
The cardinal symptoms of PD include bradykinesia, resting tremor, rigidity, and postural instability. However, non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders are also prevalent and significantly impact patients' quality of life.
PD diagnosis is primarily clinical, based on the presence of characteristic motor symptoms. Neuroimaging techniques like DAT-SPECT can support the diagnosis but are not routinely used due to their high cost and limited availability. There are no specific biomarkers for PD, making early diagnosis challenging.
Treatment of PD is symptomatic, with levodopa being the most effective medication for motor symptoms. However, its long-term use is associated with motor complications. Other treatment options include dopamine agonists, MAO-B inhibitors, and deep brain stimulation for refractory cases.
Current research efforts are focused on understanding the genetic and environmental factors contributing to PD's pathogenesis, identifying reliable biomarkers for early diagnosis, and developing disease-modifying therapies.
PD is a complex disorder with a significant impact on patients' lives. As medical professionals, we must stay abreast of the latest research to provide the best care for our patients and contribute to the ongoing efforts to unravel the mysteries of this disease.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation